Evidence map›Paper›PMID 24739384›Full record

ArticleThe Journal of biological chemistry2014

Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation.

Alexey Belogurov, Anna Kudriaeva, Ekaterina Kuzina, Ivan Smirnov, Tatyana Bobik, Natalia Ponomarenko, Yelena Kravtsova-Ivantsiv, Aaron Ciechanover, Alexander Gabibov

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alexey BelogurovFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia, the Institute of Gene Biology, Russian Academy of Sciences, 117334 Moscow, Russia.
Anna KudriaevaFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia.
Ekaterina KuzinaFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia, the Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia, and.
Ivan SmirnovFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia, the Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia, and.
Tatyana BobikFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia.
Natalia PonomarenkoFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia.
Yelena Kravtsova-Ivantsivthe Cancer and Vascular Biology Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel.
Aaron Ciechanoverthe Cancer and Vascular Biology Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel c_tzachy@netvision.net.il.
Alexander GabibovFrom the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117871 Moscow V-437, Russia, the Institute of Gene Biology, Russian Academy of Sciences, 117334 Moscow, Russia, the Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia, and gabibov@mx.ibch.ru.
Institute of Bioorganic Chemistry · RULomonosov Moscow State University · RUTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vast majority of cellular proteins are degraded by the 26S proteasome after their ubiquitination. Here, we report that the major component of the myelin multilayered membrane sheath, myelin basic protein (MBP), is hydrolyzed by the 26S proteasome in a ubiquitin-independent manner both in vitro and in mammalian cells. As a proteasomal substrate, MBP reveals a distinct and physiologically relevant concentration range for ubiquitin-independent proteolysis. Enzymatic deimination prevents hydrolysis of MBP by the proteasome, suggesting that an abnormally basic charge contributes to its susceptibility toward proteasome-mediated degradation. To our knowledge, our data reveal the first case of a pathophysiologically important autoantigen as a ubiquitin-independent substrate of the 26S proteasome.

Indexed as

Multiple SclerosisProteolysisUbiquitinationAnimalsAutoantigensHEK293 CellsHeLa CellsHumansMiceMice, Inbred BALB CMyelin Basic ProteinProteasome Endopeptidase ComplexATP dependent 26S proteaseAutoantigensMyelin Basic ProteinProteasome Endopeptidase ComplexAntigen ProcessingAutoimmune DiseaseMultiple SclerosisMyelinOligodendrocyteProteasomeUbiquitin

Identifiers

PMID24739384
PMCPMC4067209
OpenAlexW2064715535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.